Evangelisches Krankenhaus Düsseldorf
11
1
1
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
EUS-directed Transenteric ERCP (EDEE) in Patients With Benign and Malignant Underlying Conditions and Inaccessible Papilla/Biliodigestive Anastomosis (BDA)
Role: lead
Recurrences After Standard EMR vs Plus Thermal Ablation EMR
Role: collaborator
Motorized Spiral Enteroscopy-assisted ERCP in Surgically Altered Anatomy
Role: lead
Digital Catheter Based Pancreatoscopy (SpyGlassDS) for the Management of Symptomatic Pancreatic Duct Stones in Selected Patients With Chronic Pancreatitis
Role: lead
Total Motorized Spiral Enteroscopy Trial
Role: lead
European Novel Motorized Spiral Endoscopy Trial
Role: lead
Endoscopic Treatment of Non-variceal Upper GI-bleeding With High Risk of Recurrency - OTSC (Over-the-scope-clip) Versus Standard Therapy (STING2)
Role: collaborator
Motorized Spiral Colonoscopy Trial: A First Feasibility Trial
Role: lead
Diagnostic Accuracy of ERCP-guided Versus Cholangioscopy-guided Tissue Acquisition in Patients With Indeterminate Biliary Strictures Suspected to be Intrinsic .
Role: collaborator
ESD Versus EMR for Treatment of Early Barrett's Adenocarcinoma
Role: lead
Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer
Role: collaborator
All 11 trials loaded